Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2 Purity >99.0% Febuxostat Intermediate Factory
Ruifu Chemical Supply Febuxostat Related Intermediates:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Chemical Name | Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate |
Synonyms | 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylic Acid Ethyl Ester; Febuxostat Intermediate |
CAS Number | 161798-01-2 |
CAT Number | RF-PI1111 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C14H13NO4S |
Molecular Weight | 291.32 |
Melting Point | 113.0 to 117.0℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | Yellow to Light Yellow Powder |
Solubility | 1.0g sample can be dissolved in 30ml dichloromethane and dimethyl sulfoxide |
UV Identification | Maximum absorption at 260nm±3nm and 321nm±3nm wavelengths |
Moisture (K.F) | ≤0.50% |
Residue on Ignition | ≤0.50% |
Unknown Single Impurity | ≤0.50% |
Total Impurities | ≤1.0% |
Purity / Analysis Method | ≥99.0% (Calculated on the anhydrous basis) |
Test Standard | Enterprise Standard |
Usage | Intermediate of Febuxostat (CAS: 144060-53-7) |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate (CAS: 161798-01-2) is an intermediate of Febuxostat (CAS: 144060-53-7). Febuxostat is a new generation xanthine oxidase inhibitor developed by Tejin Co. (Japan,) used clinically for for long-term treatment of hyperuicemia (gout,) a new and highly effective non-purine selective inhibitor of xanthine oxidase. It is not recommended for gout patients without hyperuricemia.